Toronto Dominion Bank Purchases 26,861 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Toronto Dominion Bank boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 8.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 356,330 shares of the pharmacy operator’s stock after buying an additional 26,861 shares during the quarter. Toronto Dominion Bank’s holdings in Walgreens Boots Alliance were worth $3,193,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in WBA. Iron Horse Wealth Management LLC increased its stake in shares of Walgreens Boots Alliance by 162.5% in the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 1,300 shares during the period. Blue Trust Inc. boosted its holdings in Walgreens Boots Alliance by 87.0% in the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 1,081 shares during the last quarter. Continuum Advisory LLC increased its position in Walgreens Boots Alliance by 71.2% during the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 1,020 shares during the period. Strategic Investment Solutions Inc. IL bought a new position in Walgreens Boots Alliance during the 2nd quarter worth approximately $34,000. Finally, First Personal Financial Services lifted its position in shares of Walgreens Boots Alliance by 83.3% in the 2nd quarter. First Personal Financial Services now owns 3,300 shares of the pharmacy operator’s stock worth $40,000 after purchasing an additional 1,500 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently weighed in on WBA. JPMorgan Chase & Co. decreased their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. UBS Group raised their target price on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. Finally, Barclays boosted their price target on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $12.58.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $10.39 on Monday. The stock’s 50 day moving average is $9.27 and its 200-day moving average is $10.69. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $27.05. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $8.98 billion, a price-to-earnings ratio of -1.04, a PEG ratio of 1.36 and a beta of 0.66.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business’s quarterly revenue was up 5.9% compared to the same quarter last year. During the same period last year, the firm earned $0.67 earnings per share. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were paid a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 9.62%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.